Drawing for IVEENA

USPTO serial 78747321

IVEENA

Reviewed by CopyMark Law Group

Reg. 3299515Status 800Renewal
Filing date
Status date
Registration date
Sep 25, 2007
Examiner
KING, CHRISTINA B
Law office
GENERIC WEB UPDATE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with IVEENA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephen J. Mayfield

Stephen J. Mayfield York Howell & Guymon6405 South 3000 East, Suite 150Salt Lake City, UT 84121

Goods and services

ClassDescriptionStatusFirst use
005anti-diabetic pharmaceuticals, cardiovascular pharmaceuticals, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, ocular pharmaceuticals, pharmaceutical preparations for use in chemotherapy, pharmaceutical preparations for the treatment of macular degeneration, corneal neovascularization, diabetic retinopathy, cancer, stroke, heart disease, wound healing; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations for ocular or intraocular surgery, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for wounds, pharmaceutical products for opthalmological use, plant extracts for medical, veterinary and pharmaceutical purposesACTIVEMar 6, 2007

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 25, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jun 5, 2017NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Jun 5, 2017RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jun 5, 201789AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
May 23, 2017EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jan 9, 2017PR89POST REGISTRATION ACTION MAILED - SEC. 8 & 9—
Jan 9, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 28, 2016E89RTEAS SECTION 8 & 9 RECEIVED—
Sep 25, 2016REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Dec 17, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 10, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 23, 2013NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Aug 22, 20138.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Aug 22, 20138.AFREGISTERED - SEC. 8 (6-YR) FILED—
Jun 20, 2013EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jun 13, 2013NA15SEC. 15 ACKNOWLEDGEMENT - E-MAILED—
Jun 13, 201315AKREGISTERED - SEC. 15 ACKNOWLEDGED—
Jun 13, 2013PRA8POST REGISTRATION ACTION MAILED - SEC. 8—
Jun 13, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 12, 2013E15RTEAS SECTION 15 RECEIVED—
Jun 12, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 7, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 7, 2013ES8RTEAS SECTION 8 RECEIVED—
Sep 25, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 22, 2007REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Aug 22, 2007ALIEASSIGNED TO LIE—
Jul 11, 2007CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 10, 2007SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 9, 2007IUAFUSE AMENDMENT FILED—
Apr 9, 2007EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 10, 2006NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 18, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 28, 2006NPUBNOTICE OF PUBLICATION—
Jun 2, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 19, 2006ALIEASSIGNED TO LIE—
May 11, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 10, 2006DOCKASSIGNED TO EXAMINER—
Nov 9, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance